MedPath

Makerere University

Makerere University logo
πŸ‡ΊπŸ‡¬Uganda
Ownership
Private
Established
1922-01-01
Employees
1K
Market Cap
-
Website
http://www.makerere.ac.ug

Optimizing HIV Virologic Outcomes for Pregnant Women in Uganda

Not Applicable
Conditions
HIV
Interventions
Behavioral: ENHANCED -SPS intervention
First Posted Date
2019-10-10
Last Posted Date
2019-10-17
Lead Sponsor
Makerere University
Target Recruit Count
980
Registration Number
NCT04122144
Locations
πŸ‡ΊπŸ‡¬

Jane Kabami, Kampala, Mbarara, Uganda

Determining Bacterial Communities in the Lungs of HIV-infected Individuals With COPD in Uganda.

Conditions
HIV/AIDS
COPD
Interventions
Other: No intervention
First Posted Date
2019-08-28
Last Posted Date
2019-08-30
Lead Sponsor
Makerere University
Target Recruit Count
200
Registration Number
NCT04070248
Locations
πŸ‡ΊπŸ‡¬

Makerere University Lung Institute, Kampala, Uganda

Effect of Intrapartum Oxygen Administration on Fetal and Early Neonatal Outcomes

Phase 3
Conditions
Fetal Distress
Birth Asphyxia
Interventions
First Posted Date
2019-08-02
Last Posted Date
2020-03-26
Lead Sponsor
Makerere University
Target Recruit Count
1108
Registration Number
NCT04043299
Locations
πŸ‡ΊπŸ‡¬

Kawempe National Referral Hospital, Kampala, Uganda

Nucleosides And Darunavir/Dolutegravir In Africa

First Posted Date
2019-06-17
Last Posted Date
2020-07-30
Lead Sponsor
Makerere University
Target Recruit Count
465
Registration Number
NCT03988452
Locations
πŸ‡ΊπŸ‡¬

Infectious Diseases Institute, Kampala, Uganda

Safety and Efficacy of High Dose Rifampicin in Tuberculosis (TB)-HIV Co-infected Patients on Efavirenz- or Dolutegravir-based Antiretroviral Therapy

Phase 2
Completed
Conditions
Tuberculosis
Interventions
First Posted Date
2019-06-11
Last Posted Date
2023-03-23
Lead Sponsor
Makerere University
Target Recruit Count
130
Registration Number
NCT03982277
Locations
πŸ‡ΊπŸ‡¬

Infectious Diseases Institute, Kampala, Uganda

Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia

Phase 2
Recruiting
Conditions
Cryptococcal Meningitis
Interventions
Drug: Single dose liposomal Amphotericin and Fluconazole
First Posted Date
2019-05-10
Last Posted Date
2023-04-12
Lead Sponsor
Makerere University
Target Recruit Count
356
Registration Number
NCT03945448
Locations
πŸ‡ΊπŸ‡¬

infectious Disease Institute Kampala,Uganda, Kampala, Uganda

Incidence and Factors Associated With PONV in Regional Anaesthesia

Completed
Conditions
Regional Anaesthesia
PONV
First Posted Date
2019-02-08
Last Posted Date
2024-08-27
Lead Sponsor
Makerere University
Target Recruit Count
364
Registration Number
NCT03835234
Locations
πŸ‡ΊπŸ‡¬

Mulago hospital, Kampala, Uganda

WHO Checklist- Based Infection Prevention Guidelines in Mulago Hospital

Conditions
Surgical Site Infection
First Posted Date
2019-01-30
Last Posted Date
2019-01-30
Lead Sponsor
Makerere University
Target Recruit Count
768
Registration Number
NCT03822039
Locations
πŸ‡ΊπŸ‡¬

Mulago hospital, Kampala, Mulago Hospital, Uganda

Mechanical Ventilation Practices in Uganda's Intensive Care Units

Conditions
Mechanically Ventilated Patients
First Posted Date
2019-01-11
Last Posted Date
2019-01-11
Lead Sponsor
Makerere University
Target Recruit Count
214
Registration Number
NCT03800849
Locations
πŸ‡ΊπŸ‡¬

Mulago hospital, Kampala, Uganda

Video-Debriefing for Improved Competence Among Skilled Birth Attendants in Lira District-Northern Uganda

Not Applicable
Conditions
Helping Babies Breathe (HBB) Training
Neonatal Encephalopathy
Interventions
Behavioral: Video-debriefing with standard HBB training compared with standard HBB training only
First Posted Date
2018-10-12
Last Posted Date
2018-10-12
Lead Sponsor
Makerere University
Target Recruit Count
96
Registration Number
NCT03703622
Locations
πŸ‡ΊπŸ‡¬

All public and Private delivery facilities (hospitals, health centers, maternity homes, and clinics) in Lira district, Lira, Northern, Uganda

Β© Copyright 2025. All Rights Reserved by MedPath